Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• Κύριοι συγγραφείς: Qi-An Chen (Συγγραφέας), Wei-Hao Lin (Συγγραφέας), Xiao-Xiang Zhou (Συγγραφέας), Zheng Cao (Συγγραφέας), Xiao-Li Feng (Συγγραφέας), Yi-Bo Gao (Συγγραφέας), Jie He (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2024-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...